Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-controlled Phase II study of Viscum fraxini in advanced hepatocellular carcinoma
2006-000673-30Phase 2Completed
- Sponsor
- Medizinische Hochschule Hannover
- Start
- Feb 2007
- Countries
- 1
01
Overview
Phase 2, randomised trial in hepatocellular carcinoma (HCC) comparing Viscum fraxini with Placebo (2 arms). Primary endpoints: Improvement of immune response and Overall survival. Started Feb 2007; status: completed.
02
Drugs
abnobaVISCUM Fraxini
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on 2006-000673-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000673-30.